相关实验视频

Updated: Sep 16, 2025

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

在帕金森病中视网膜结构变化和衰老:来自波斯队列研究的证据

Farzaneh Nikparast¹, Zohreh Ganji¹, Nooshin Akbari-Sharak²

¹Student research committee, Mashhad University of medical sciences, Mashhad, Iran; Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Photodiagnosis and photodynamic therapy

|July 11, 2025

概括

在帕金森病 (PD) 患者中,视网膜变薄和视神经参数增加可能表明PD. 这些视网膜变化,包括周围膜厚度和质细胞复合体 (GCC) 体积,与PD的年龄密切相关.

科学领域:

眼科医生眼科眼科
神经学神经学
生物标志物发现发现

背景情况:

帕金森病 (PD) 影响大脑和视网膜.
视网膜与大脑的结构相似性表明它有可能成为PD检测和监测的非侵入性生物标志物.

研究的目的:

用光学连贯断层扫描 (OCT) 和帕金森病患者的实验室数据调查视网膜结构变化.
探索视网膜作为PD生物标志物的潜力.

主要方法:

对125名PD患者和972名对照患者的斑点和周周斑点OCT参数和实验室结果的分析.
使用独立样本 t 测试或曼·惠特尼 U 测试进行组对比.
通过皮尔森或斯皮尔曼等级相关性评估OCT测量和年龄之间的关联.

主要成果:

在PD患者中观察到显著的外周视网膜稀薄,特别是在两个眼睛的特定象限和半球.
在PD患者中观察到光盘面积增加和焦点损失体积.
在PD组中,与年龄相关的围状视网膜神经纤维层 (pRNFL) 和质细胞复合体 (GCC) 厚度的减少更为明显.

结论:

减少周围膜厚度和体积,以及增加视神经OCT参数,可能作为PD的潜在诊断生物标志物.
在帕金森病患者中,pRNFL,GCC和外周视网膜厚度与年龄有着强烈的关联.

关键词:

生物标志物生物标志物帕金森病是帕金森氏症的一种疾病.视网膜 (retina) 是一个视网膜.视网膜神经纤维层是一种神经纤维层.光学连贯性断层扫描 (optical coherence tomography) 是一种光学连贯性断层扫描技术.

更多相关视频

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...